BIIB

Biogen Inc. is a global biotechnology company recognized for its research and development in neurology. Headquartered in Cambridge, Massachusetts, the firm focuses on discovering, developing, and delivering therapies for patients living with serious neurological and neurodegenerative diseases, including multiple sclerosis, spinal muscular atrophy, and Alzheimer’s disease.